Chemoinformaics analysis of 15-Tetracosenoic acid metyl ester
| Molecular Weight | 380.657 | nRot | 21 |
| Heavy Atom Molecular Weight | 332.273 | nRig | 2 |
| Exact Molecular Weight | 380.365 | nRing | 0 |
| Solubility: LogS | -7.222 | nHRing | 0 |
| Solubility: LogP | 9.945 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 75.3601 |
| nHD | 0 | BPOL | 50.7579 |
| QED | 0.113 |
| Synth | 2.15 |
| Natural Product Likeliness | 0.566 |
| NR-PPAR-gamma | 0.142 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.97 |
| MDCK | 0.0000101 |
| BBB | 0.043 |
| PPB | 0.981034 |
| VDSS | 4.262 |
| FU | 0.0138843 |
| CYP1A2-inh | 0.133 |
| CYP1A2-sub | 0.163 |
| CYP2c19-inh | 0.235 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.966 |
| CYP2d6-inh | 0.221 |
| CYP2d6-sub | 0.047 |
| CYP3a4-inh | 0.324 |
| CYP3a4-sub | 0.028 |
| CL | 4.863 |
| T12 | 0.091 |
| hERG | 0.403 |
| Ames | 0.004 |
| ROA | 0.007 |
| SkinSen | 0.979 |
| Carcinogencity | 0.05 |
| EI | 0.913 |
| Respiratory | 0.563 |
| NR-Aromatase | 0.124 |
| Antiviral | No |
| Prediction | 0.581282 |